CD8A and neoplasm: Using melanoma models, we also identify two sequential phases of antitumor response triggered by LTX-315: the first phase is lymphocyte independent and defined by rapid disruption of the tumor vasculature, the second phase is defined by long-term alteration of the tumor microenvironment and infiltration by CD8+ T cells, which display antitumor functions.